IndustryCompany release

Alphatec lowers 2026 outlook after Q3 revenue of $221 million misses expectations

🇺🇸 Alphatec Holdings, Inc. (ATEC) · Thu 29 Oct 2026

The spine surgery company blamed weaker biologics attachment for the shortfall and now expects full-year revenue of about $862 million.

Alphatec Holdings (Nasdaq: ATEC), a spine surgery company, reported results for the quarter ended 30 September 2026 on 29 October. Revenue was $221 million, up 13%, but the company said this fell short of its own expectations.

Surgical revenue rose 14% in the quarter. Alphatec recorded a GAAP net loss of $5 million.

Management attributed the revenue shortfall to weaker biologics attachment. The company did not provide further detail in the material available to VigiEye.

Alphatec has lowered its 2026 outlook. It now expects full-year revenue of about $862 million and adjusted EBITDA of about $137 million.

What it means for your team

  • Companies in the spine and orthobiologics space may see product-mix effects, such as weaker attachment of biologics to surgical procedures, feed through to results and guidance.
  • Market-access and commercial teams tracking Alphatec should note the revised full-year figures: about $862 million in revenue and about $137 million in adjusted EBITDA.
  • The available information contains no regulatory, safety or quality findings, so the update bears on commercial performance rather than compliance.

Company's press release (SEC filing): Alphatec Holdings, Inc. ↗

Article written by VigiEye from the official source (Alphatec Holdings, Inc.). Claims are the company's own. AI-assisted; check the source before acting.

More Industry All →